Multiple-dose ponezumab for mild-to-moderate Alzheimer's disease: Safety and efficacy. - Landen JW; Cohen S; Billing CB Jr; Cronenberger C; Styren S; Burstein AH; Sattler C; Lee JH; Jack CR Jr; Kantarci K; Schwartz PF; Duggan WT; et al. (Alzheimer's & dementia (New York, N. Y.), 2017)